Metagenomi, Inc.
MGX
Revenue
20.01M
▲8.85M▲79.30%
3 Months ChangeAssets
385.91M
▼-29.50M▼-7.10%
3 Months ChangeLiabilities
116.49M
▼-23.28M▼-16.66%
3 Months ChangeFree Cash Flow
-30.77M
▼-7.10M▼-30.01%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-03
Form 8-K
ID: 0000950170-24-102805
2024-08-14
Form 8-K
ID: 0000950170-24-096673
2024-08-14
Form 10-Q
ID: 0000950170-24-096665
2024-05-14
Form 8-K
ID: 0000950170-24-059532
2024-05-14
Form 10-Q
ID: 0000950170-24-059504
2024-05-01
Form 8-K
ID: 0000950170-24-051238
2024-03-27
Form 8-K
ID: 0000950170-24-036847
2024-02-13
Form 8-K
ID: 0001193125-24-033697